Is this miracle drug the answer for aging dogs?

Loyal, the biotech trailblazer in pet longevity, has embarked on a groundbreaking journey with the launch of its STAY study, administering the first dose of the promising LOY-002 drug to Boo, an 11-year-old Whippet. This monumental trial is not just a medical first but a beacon of hope for pet owners dreaming of more quality time with their aging furry friends.